USA flag logo/image

An Official Website of the United States Government

Adenoviral Mediated Gene Therapy for Experimental Glioma

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
29220
Program Year/Program:
1997 / SBIR
Agency Tracking Number:
29220
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
TSRL, INC.
540 AVIS DR, STE A ANN ARBOR, MI -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1997
Title: Adenoviral Mediated Gene Therapy for Experimental Glioma
Agency: HHS
Contract: 1 R43 CA67357-01,
Award Amount: $632,576.00
 

Abstract:

Gliomas are the most common primary intracranial brain tumors and are thought to arise as a neoplastransformation of glial cells in the central nervous system. The prognosis for the disease is poor.surgical resection of the tumor followed by radiation or chemotherapy. This application describes analternative treatment strategies. The effectiveness of an adenovirus vector to deliver the herpes sikinase (tk) gene to inhibit selectively tumor cell growth upon receipt of ganciclovir (GCV) will beadenovirus vector will be specifically introduced into the tumor area by stereotactic injection; GCVsystemically. The plan is to optimize growth inhibition by determining the effectiveness of redosingdeveloping long term release of infectious virions into the surrounding environment.

Principal Investigator:

John Hilfinger
31362

Business Contact:

Small Business Information at Submission:

Tsrl, Inc.
540 Avis Drive, Suite A Ann Arbor, MI 48108

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No